Safety of interferon &beta; treatment for chronic HCV hepatitis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

235

HTML

2175

Tables (1-2)

234

Sum=2644

Jan 1, 2004 (publication date) through Jan 8, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jan 1, 2004; 10(1): 12-16
Published online Jan 1, 2004. doi: 10.3748/wjg.v10.i1.12

Table 1 Frequency of treatment discontinuation and dose modifications during therapy with IFNβ.

Citation: Festi D, Sandri L, Mazzella G, Roda E, Sacco T, Staniscia T, Capodicasa S, Vestito A, Colecchia A. Safety of interferon β treatment for chronic HCV hepatitis. World J Gastroenterol 2004; 10(1): 12-16
URL: https://www.wjgnet.com/1007-9327/full/v10/i1/12.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i1.12